Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Moodys
Johnson and Johnson
Dow
AstraZeneca
Harvard Business School
McKesson

Last Updated: January 27, 2023

Desmopressin acetate - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What are the generic sources for desmopressin acetate and what is the scope of freedom to operate?

Desmopressin acetate is the generic ingredient in eleven branded drugs marketed by Ferring Pharms Inc, Am Regent, Bedford, Dr Reddys, Gland Pharma Ltd, Hospira, Sagent Pharms Inc, Sun Pharm Inds Ltd, Teva Pharms Usa, UBI, Ferring, Sun Pharm Inds, Bausch, Apotex Inc, Sun Pharm, Zydus Pharms, Acerus Pharms, Abhai Llc, Actavis Labs Fl Inc, Glenmark Pharms Ltd, Heritage Pharma, Impax Labs Inc, Mylan, and Novast Labs, and is included in thirty-four NDAs. There are thirteen patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Desmopressin acetate has two hundred and five patent family members in thirty-six countries.

There are thirteen drug master file entries for desmopressin acetate. Twenty-five suppliers are listed for this compound.

Drug Prices for desmopressin acetate

See drug prices for desmopressin acetate

Recent Clinical Trials for desmopressin acetate

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Cairo UniversityN/A
Genentech, Inc.Phase 4
Indiana Hemophilia &Thrombosis Center, Inc.Phase 4

See all desmopressin acetate clinical trials

US Patents and Regulatory Information for desmopressin acetate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Acerus Pharms NOCTIVA desmopressin acetate SPRAY, METERED;NASAL 201656-001 Mar 3, 2017 DISCN Yes No See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
Ferring Pharms Inc NOCDURNA desmopressin acetate TABLET;SUBLINGUAL 022517-001 Jun 21, 2018 RX Yes No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Mylan DESMOPRESSIN ACETATE desmopressin acetate TABLET;ORAL 200653-002 Jun 27, 2014 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for desmopressin acetate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Ferring Pharms Inc DDAVP desmopressin acetate TABLET;ORAL 019955-002 Sep 6, 1995 See Plans and Pricing See Plans and Pricing
Ferring Pharms Inc DDAVP desmopressin acetate SPRAY, METERED;NASAL 017922-002 Feb 6, 1989 See Plans and Pricing See Plans and Pricing
Ferring Pharms Inc DDAVP (NEEDS NO REFRIGERATION) desmopressin acetate SPRAY, METERED;NASAL 017922-003 Aug 7, 1996 See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Supplementary Protection Certificates for desmopressin acetate

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
3225249 2019C/520 Belgium See Plans and Pricing PRODUCT NAME: DESMOPRESSINE OF EEN ACETAATZOUT DAARVAN; AUTHORISATION NUMBER AND DATE: BE497271 - BE497280 20160513
2712622 122017000006 Germany See Plans and Pricing PRODUCT NAME: DESMOPRESSIN ODER DAS ACETAT DAVON; NAT. REGISTRATION NO/DATE: 94725.00.00 94726.00.00 20160901 FIRST REGISTRATION: BELGIEN BE497271 BE497280 20160504
3225249 300983 Netherlands See Plans and Pricing PRODUCT NAME: DESMOPRESSIN, DESGEWENST IN DE VORM VAN EEN ACETAAT ZOUT; REGISTRATION NO/DATE: BE497271 & BE497280 20160513
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Boehringer Ingelheim
Colorcon
McKesson
Express Scripts
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.